Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Open-market sale 10% owner sold 16 shares at $12.93 ($207)
  2. 4 Exercise or conversion Chief Financial Officer acquired 9,500 shares (option exercise)
  3. 4 Open-market sale 10% owner sold 2,056 shares at $12.14 ($24,960)
  4. 4 Open-market sale 10% owner sold 5,893 shares at an average $12.29 ($72,412)
  5. 4 Exercise or conversion Chief Operating Officer acquired 9,225 shares (option exercise)
  6. 4 Exercise or conversion President and CEO acquired 33,605 shares (option exercise)
  7. 4 Open-market buy 10% owner bought 400,000 shares at $12.50 ($5,000,000)
  8. 4 Open-market buy Director bought 3,389,500 shares at $12.50 ($42,368,750)
  9. 4 Conversion 10% owner acquired 888,130 shares (conversion)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Chief Medical Officer acquired 20,030 shares (grant or award)
  16. 4 Grant or award Chief Operating Officer acquired 33,383 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 20,030 shares (grant or award)
  18. 4 Grant or award EVP - Business Operations acquired 1,524,947 shares (grant or award)
  19. 4 Grant or award President and CEO acquired 1,524,947 shares (grant or award)
  20. 3/A Insider 3/A

Page 10 of 11 · 211 filings